OECD insights blog: Francesca Colombo, Head of the OECD Health Division, discusses the issues related to health systems and an ageing population.
Dementia is increasing in prevalence, and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Further, moving beyond established medical data into big data offers the potential to tap into routinely collected data from both within and outside the health system.
Improving labour market participation of people with mental health problems requires well-integrated policies and services across the education, employment, health and social sectors. This paper provides examples of policy initiatives from 10 OECD countries for integrated services.
More than 35 million people worldwide had dementia in 2010 and this number is expected to exceed 115 million by 2050. This paper reports on the opportunities offered by the informatics revolution and big data to address Alzheimer’s Disease and dementia. This will require careful planning and multi-stakeholder collaboration as technical, administrative, regulatory, infrastructure and financial obstacles emerge.
An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.
English, PDF, 346kb
Health spending per capita in real terms fell by 2% in Italy in 2011, and is estimated to have fallen by a further 0.4% in 2012. Spending per capita also fell in 10 other European countries between 2009 and 2011, following the recession and the need for fiscal consolidation, according to a new OECD report.
English, PDF, 467kb
Ireland continues to make substantive headway in improving health outcomes, but more can be done in reducing risk-factors for major diseases and improving value-for-money in health spending, according to a new OECD report.
This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.
La Belgique a su se doter de services de santé accessibles, mais le morcellement des responsabilités au sein du système et le poids de la réglementation risquent de rendre l’adaptation au vieillissement de la population difficile.